Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds. 1993

P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
Department of Pathology, University of Leiden, The Netherlands.

We have performed linkage analysis with five markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds in order to find support for the claim by Hall et al. that a gene in this region, termed "BRCA1," is associated with predisposition to early-onset familial breast cancer. This work is part of a collaborative study, the results of which are published elsewhere in this issue. Best evidence for linkage was observed with the marker CMM86 (D17S74) in pedigrees with an average age at onset of < or = 47 years (LOD score = 1.77 at 1% recombination). In one breast-ovarian cancer family with a high probability of being linked to 17q, we observed one putative recombinant between D17S250 and D17S579, which suggests that BRCA1 is proximal to D17S579.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008126 Lod Score The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds." Lod Scores,Score, Lod,Scores, Lod
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009386 Neoplastic Syndromes, Hereditary The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance. Cancer Syndromes, Hereditary,Hereditary Cancer Syndromes,Hereditary Neoplastic Syndromes,Cancer Syndrome, Hereditary,Hereditary Cancer Syndrome,Hereditary Neoplastic Syndrome,Neoplastic Syndrome, Hereditary,Syndrome, Hereditary Cancer,Syndrome, Hereditary Neoplastic,Syndromes, Hereditary Cancer,Syndromes, Hereditary Neoplastic
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms

Related Publications

P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
September 1994, Human molecular genetics,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
September 1993, Genomics,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
September 1993, Genomics,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
April 1993, American journal of human genetics,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
December 1994, International journal of cancer,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
June 1999, American journal of human genetics,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
April 1993, American journal of human genetics,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
January 2016, PloS one,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
July 1995, Genes, chromosomes & cancer,
P Devilee, and R S Cornelis, and A Bootsma, and A Bardoel, and M van Vliet, and I van Leeuwen, and F J Cleton, and A de Klein, and D Lindhout, and H F Vasen
October 1995, Human genetics,
Copied contents to your clipboard!